
Samhep-TAF 25mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Tenofovir Alafenamide (25mg)
Overview Samhep-TAF 25mg Tablet
Tenofovir Alafenamide 25mg tablets combat HIV and chronic hepatitis B (HBV) infections by hindering viral replication within human cells, thus suppressing viral load and aiding infection resolution. Dosage and treatment duration should strictly adhere to your physician's instructions; complete the prescribed course regardless of symptom improvement. Administer with food to optimize absorption. Continued use is crucial until medically advised otherwise. Headache, diarrhea, nausea, arthralgia, abdominal discomfort, and dyspepsia are common, typically mild, but persistent symptoms warrant medical attention. Rarely, skin reactions or hepatic impairment may occur, necessitating close monitoring, especially initially. Pre-existing dermatological, hepatic, or renal conditions should be disclosed before commencing treatment. Regular blood tests to assess hematological parameters and liver function are often required. Alcohol consumption should be avoided due to increased hepatotoxicity risk. Pregnant or lactating individuals must seek medical counsel prior to use. Unsafe sexual practices and sharing personal items are discouraged for HIV-positive patients; discuss safe sex practices, including condom use, with your doctor to mitigate transmission risk.
Primary Ingredients of Samhep-TAF 25mg Tablet
No text was provided to rewrite.
Uses of Samhep-TAF 25mg Tablet
Managing persistent Hepatitis B virus (HBV) infection
Major Benefits of Samhep-TAF 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg Samhep-TAF Tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
Common Side effects of Samhep-TAF 25mg Tablet:
- Headache
- Diarrhea
- Nausea
- Fatigue
- Abdominal pain
- Cough
- Back pain
- Indigestion
- Joint pain
How to use Samhep-TAF 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Samhep-TAF 25mg Tablet should be administered with a meal.
How Samhep-TAF 25mg Tablet works:
Tenofovir alafenamide 25mg tablets (Samhep-TAF) are an antiviral drug. They inhibit viral replication within human cells, thus halting further viral production and resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Samhep-TAF 25mg tablets may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Samhep-TAF 25mg tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Samhep-TAF 25mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking a Samhep-TAF 25mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with kidney impairment should use Samhep-TAF 25mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Samhep-TAF 25mg tablets in individuals with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, but physician consultation is advised.
What if you forget to take Samhep-TAF 25mg Tablet :
Should you forget to take a Samhep-TAF 25mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Samhep-TAF 25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Base analog |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Actions | Reverse transcriptase inhibitors (RTIs) that are nucleosides or nucleotides |
